Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

TECNALIA Publications
Publicación Artículo científico (JournalArticle)

Information fusion as an integrative cross-cutting enabler to achieve robust, explainable, and trustworthy medical artificial intelligence

  • Holzinger, Andreas
  • Dehmer, Matthias
  • Emmert-Streib, Frank
  • Cucchiara, Rita
  • Augenstein, Isabelle
  • Ser, Javier Del
  • Samek, Wojciech
  • Jurisica, Igor
  • Díaz-Rodríguez, Natalia
Medical artificial intelligence (AI) systems have been remarkably successful, even outperforming human performance at certain tasks. There is no doubt that AI is important to improve human health in many ways and will disrupt various medical workflows in the future. Using AI to solve problems in medicine beyond the lab, in routine environments, we need to do more than to just improve the performance of existing AI methods. Robust AI solutions must be able to cope with imprecision, missing and incorrect information, and explain both the result and the process of how it was obtained to a medical expert. Using conceptual knowledge as a guiding model of reality can help to develop more robust, explainable, and less biased machine learning models that can ideally learn from less data. Achieving these goals will require an orchestrated effort that combines three complementary Frontier Research Areas: (1) Complex Networks and their Inference, (2) Graph causal models and counterfactuals, and (3) Verification and Explainability methods. The goal of this paper is to describe these three areas from a unified view and to motivate how information fusion in a comprehensive and integrative manner can not only help bring these three areas together, but also have a transformative role by bridging the gap between research and practical applications in the context of future trustworthy medical AI. This makes it imperative to include ethical and legal aspects as a cross-cutting discipline, because all future solutions must not only be ethically responsible, but also legally compliant.
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Information fusion as an integrative cross-cutting enabler to achieve robust, explainable, and trustworthy medical artificial intelligence

  • Holzinger, Andreas
  • Dehmer, Matthias
  • Emmert-Streib, Frank
  • Cucchiara, Rita
  • Augenstein, Isabelle
  • Del Ser, Javier
  • Samek, Wojciech
  • Jurisica, Igor
  • Díaz Rodríguez, Natalia Ana|||0000-0003-3362-9326
Andreas Holzinger acknowledges funding support from the Austrian Science Fund (FWF), Project: P-32554 explainable Artificial Intelligence and from the European Union's Horizon 2020 research and innovation program under grant agreement 826078 (Feature Cloud). This publication reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains; Natalia Diaz-Rodriguez is supported by the Spanish Government Juan de la Cierva Incorporacion contract (IJC2019-039152-I); Isabelle Augenstein's research is partially funded by a DFF Sapere Aude research leader grant; Javier Del Ser acknowledges funding support from the Basque Government through the ELKARTEK program (3KIA project, KK-2020/00049) and the consolidated research group MATHMODE (ref. T1294-19); Wojciech Samek acknowledges funding support from the European Union's Horizon 2020 research and innovation program under grant agreement No. 965221 (iToBoS), and the German Federal Ministry of Education and Research (ref. 01IS18025 A, ref. 01IS18037I and ref. 0310L0207C); Igor Jurisica acknowledges funding support from Ontario Research Fund (RDI 34876), Natural Sciences Research Council (NSERC 203475), CIHR Research Grant (93579), Canada Foundation for Innovation (CFI 29272, 225404, 33536), IBM, Ian Lawson van Toch Fund, the Schroeder Arthritis Institute via the Toronto General and Western Hospital Foundation., Medical artificial intelligence (AI) systems have been remarkably successful, even outperforming human performance at certain tasks. There is no doubt that AI is important to improve human health in many ways and will disrupt various medical workflows in the future. Using AI to solve problems in medicine beyond the lab, in routine environments, we need to do more than to just improve the performance of existing AI methods. Robust AI solutions must be able to cope with imprecision, missing and incorrect information, and explain both the result and the process of how it was obtained to a medical expert. Using conceptual knowledge as a guiding model of reality can help to develop more robust, explainable, and less biased machine learning models that can ideally learn from less data. Achieving these goals will require an orchestrated effort that combines three complementary Frontier Research Areas: (1) Complex Networks and their Inference, (2) Graph causal models and counterfactuals, and (3) Verification and Explainability methods. The goal of this paper is to describe these three areas from a unified view and to motivate how information fusion in a comprehensive and integrative manner can not only help bring these three areas together, but also have a transformative role by bridging the gap between research and practical applications in the context of future trustworthy medical AI. This makes it imperative to include ethical and legal aspects as a cross-cutting discipline, because all future solutions must not only be ethically responsible, but also legally compliant., Austrian Science Fund (FWF) P-32554, European Union's Horizon 2020 research and innovation program 826078 965221, Spanish Government Juan de la Cierva Incorporacion IJC2019-039152-I, DFF Sapere Aude research leader grant, Basque Government KK-2020/00049, consolidated research group MATHMODE T1294-19, Federal Ministry of Education & Research (BMBF) 01IS18025 A 01IS18037I 0310L0207C, Ontario Research Fund RDI 34876, Natural Sciences Research Council NSERC 203475, Canadian Institutes of Health Research (CIHR) 93579, Canada Foundation for Innovation CGIAR CFI 29272 225404 33536, International Business Machines (IBM), Ian Lawson van Toch Fund, Schroeder Arthritis Institute via the Toronto General and Western Hospital Foundation
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selection of Quality Indicators for the Certification of Dermato-Oncology Units: The CUDERMA Project Delphi Consensus Study, Proyecto CUDERMA: Consenso Delphi de los indicadores de calidad para la certificación de las unidades de dermatología de atención en dermato-oncología

  • Espronceda Ezquerro, I. Martínez de
  • Podlipnik, S.
  • Cañueto, Javier
  • Cuadra-Grande, A. de la
  • Serra-Guillén, C
  • Moreno, D.
  • Ferrándiz, L.
  • Domínguez-Cruz, J.
  • Cueva, P. de la
  • Gilaberte, Y.
  • Arias-Santiago, S.
[EN]: Quality indicators are crucial for standardizing and guaranteeing the quality of health care practices. The Spanish Academy of Dermatology and Venereology (AEDV) launched the CUDERMA Project to define quality indicators for the certification of specialized units in dermatology; the first 2 areas selected were psoriasis and dermato-oncology. The aim of this study was to achieve consensus on what should be evaluated by these indicators using a structured process comprising a literature review and selection of an initial list of indicators to be evaluated in a Delphi consensus study following review by a multidisciplinary group of experts. The selected indicators were evaluated by a panel of 28 dermatologists and classified as either «essential» or «of excellence». The panel agreed on 84 indicators, which will be standardized and used to develop the certification standard for dermato-oncology units., [ES]: Los indicadores de calidad son una herramienta clave como garantía de calidad y homogenización de la asistencia sanitaria. En este contexto, la Academia Española de Dermatología y Venereología ha diseñado el proyecto CUDERMA (Certificación de unidades de dermatología), una iniciativa que busca definir indicadores de calidad para certificar unidades de dermatología en distintos ámbitos, entre los que se seleccionaron psoriasis y dermato-oncología de forma inicial. Este estudio tuvo por objetivo consensuar los aspectos a evaluar por los indicadores, siguiendo un proceso estructurado para la revisión bibliográfica y elaboración de un set preliminar de indicadores, revisado por un grupo multidisciplinar de expertos, para su evaluación mediante un Consenso Delphi. Un panel de 28 dermatólogos evaluó los indicadores y los clasificó como «básicos» o «de excelencia», generando un conjunto de 84 indicadores consensuados que serán estandarizados para diseñar la norma con la que certificar las unidades de dermato-oncología., El proyecto ha sido impulsado y financiado por la Academia Española de dermatología y Venereología (AEDV) con una beca sin restricciones de Abbvie. La actividad de investigación científica realizada en la Unidad de Melanoma del Hospital Clínic de Barcelona es parcialmente apoyada por las becas PI15/00716, PI15/00956, PI18/00959, PI22/01457 y PI18/00419, procedentes del Fondo de Investigaciones Sanitarias (España), del CIBER de Enfermedades Raras del Instituto de Salud Carlos III, cofinanciada por ISCIII – Subdirección General de Evaluación y European Regional Devel Fund (ERDF), «A way to make Europe»; AGAUR 2017 SGR 1134 y el Programa CERCA de la Generalitat de Catalunya (España); European Commission under the 6th Framework Programme, Diagnoptics, y European Commission under the HORIZON2020 Framework Programme, iTobos (965221) y Qualitop (875171); National Cancer Institute (NCI) del National Institute of Health (NIH) de Estados Unidos (CA83115). También recibe una beca de la Fundació La Marató de TV3, 201331-30 y 201923-30 (Cataluña, España); y una beca de «Fundación Científica de la Asociación Española Contra el Cáncer» GCB15152978SOEN (España). Una parte de su trabajo se realiza en el Centro Esther Koplowitz (Barcelona). La actividad de investigación científica de Javier Cañueto es parcialmente apoyada por la beca GRS2139/A/20 (Gerencia Regional de Salud de Castilla y León), por el Instituto de Salud Carlos III (PI21/01207), cofinanciada por fondos FEDER y por el «Programa de Intensificación del ISCIII» (número de beca INT20/00074)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Going Smaller: Attention-based models for automated melanoma diagnosis

  • Nazari, Sana
  • García Campos, Rafael
Computational approaches offer a valuable tool to aid with the early diagnosis of melanoma by increasing both the speed and accuracy of doctors’ decisions. The latest and best-performing approaches often rely on large ensemble models, with the number of trained parameters exceeding 600 million. However, this large parameter count presents considerable challenges in terms of computational demands and practical application. Addressing this gap, our work introduces a suite of attention-based convolutional neural network (CNN) architectures tailored to the nuanced classification of melanoma. These innovative models, founded on the EfficientNet-B3 backbone, are characterized by their significantly reduced size. This study highlights the feasibility of deploying powerful, yet compact, diagnostic models in practical settings, such as smartphone-based dermoscopy, and in doing so revolutionizing point-of-care diagnostics and extending the reach of advanced medical technologies to remote and under-resourced areas. It presents a comparative analysis of these novel models with the top three prize winners of the International Skin Imaging Collaboration (ISIC) 2020 challenge using two independent test sets. The results for our architectures outperformed the second and third-placed winners and achieved comparable results to the first-placed winner. These models demonstrated a delicate balance between efficiency and accuracy, holding their ground against larger models in performance metrics while operating on up to 98% less number of parameters and showcasing their potential for real-time application in resource-limited environments, This work was partially funded through the European Commission’s Horizon 2020 program through the iToBoS project (grant number SC1-BHC-06-2020-965221) and the IFUDG 2022 grant, Open Access funding provided thanks to the CRUE-CSIC agreement with Elsevier, 3
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Automatic Skin Cancer Detection Using Clinical Images: A Comprehensive Review

  • Nazari, Sana
  • García Campos, Rafael
Skin cancer has become increasingly common over the past decade, with melanoma being the most aggressive type. Hence, early detection of skin cancer and melanoma is essential in dermatology. Computational methods can be a valuable tool for assisting dermatologists in identifying skin cancer. Most research in machine learning for skin cancer detection has focused on dermoscopy images due to the existence of larger image datasets. However, general practitioners typically do not have access to a dermoscope and must rely on naked-eye examinations or standard clinical images. By using standard, off-the-shelf cameras to detect high-risk moles, machine learning has also proven to be an effective tool. The objective of this paper is to provide a comprehensive review of image-processing techniques for skin cancer detection using clinical images. In this study, we evaluate 51 state-of-the-art articles that have used machine learning methods to detect skin cancer over the past decade, focusing on clinical datasets. Even though several studies have been conducted in this field, there are still few publicly available clinical datasets with sufficient data that can be used as a benchmark, especially when compared to the existing dermoscopy databases. In addition, we observed that the available artifact removal approaches are not quite adequate in some cases and may also have a negative impact on the models. Moreover, the majority of the reviewed articles are working with single-lesion images and do not consider typical mole patterns and temporal changes in the lesions of each patient, This work was partially funded through the European Commission’s Horizon 2020 program as part of the iToBoS project (grant number SC1-BHC-06-2020-965221)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Skin region images extracted from 3D total body photographs for lesion detection

  • Saha, Anup
  • Adeola, Joseph
  • Ferrera, Nuria
  • Mothershaw, Adam
  • Rezze, Gisele
  • Gaborit, Séraphin
  • D’Alessandro, Brian
  • Voskanyan, Robert
  • Szabó, Gyula
  • Pataki, Balázs
  • Rajani, Hayat
  • Nazari, Sana
  • Hayat, Hassan
  • Serra-García, Laura
  • Primiero, Clare
  • Bonin, Serena
  • Zalaudek, Iris
  • Soyer, H. Peter
  • Malvehy, Josep
  • Garcia, Rafael
Artificial intelligence has significantly advanced skin cancer diagnosis by enabling rapid and accurate detection of malignant lesions. In this domain, most publicly available image datasets consist of single, isolated skin lesions positioned at the centre of the image. While these lesion-centric datasets have been fundamental for developing diagnostic algorithms, they lack the context of the surrounding skin, which is critical for improving lesion detection. The iToBoS dataset was created to address this challenge. It includes 16,954 images of skin regions from 100 participants, captured using 3D total body photography. Each image roughly corresponds to a 7 × 9 cm section of skin with all suspicious lesions annotated using bounding boxes. Additionally, the dataset provides metadata such as anatomical location, age group, and sun damage score for each image. This dataset was designed with the aim of facilitating the training and benchmarking of algorithms, in order to enable early detection of skin cancer and deployment of this technology in non-clinical environments, This work was funded by the European Union through the iToBoS project (SC1-BHC-06-2020-965221). In addition, we extend our sincere gratitude to the clinical staff at each participating center for their efforts in capturing patient images using the VECTRA WB360 scanner, and to the patients themselves for generously contributing their images to the dataset, 3, 9